Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Other Non-Cash Items 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly other non-cash items history and growth rate from 2010 to 2024. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
  • Takeda Pharmaceutical other non-cash items for the quarter ending December 31, 2024 were $0.693B, a 7.54% decline year-over-year.
  • Takeda Pharmaceutical other non-cash items for the twelve months ending December 31, 2024 were $6.367B, a 23.23% increase year-over-year.
  • Takeda Pharmaceutical annual other non-cash items for 2025 were $2.69B, a 25.85% increase from 2024.
  • Takeda Pharmaceutical annual other non-cash items for 2024 were $2.137B, a 2.34% decline from 2023.
  • Takeda Pharmaceutical annual other non-cash items for 2023 were $2.188B, a 20.73% decline from 2022.
  
Takeda Pharmaceutical Annual Other Non-Cash Items
(Millions of US $)
2025 $2,690
2024 $2,137
2023 $2,188
2022 $2,761
2021 $-346
2020 $1,393
2019 $-96
2018 $42
2017 $-850
2016 $194
2015 $-397
2014 $33
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $45.565B $30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.255B 31.25
Zoetis (ZTS) United States $67.231B 25.08
Daiichi Sankyo, - (DSNKY) Japan $46.317B 23.74
BeOne Medicines - (ONC) Cayman Islands $33.509B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.995B 0.00
Summit Therapeutics (SMMT) United States $19.859B 0.00
Merck (MKKGY) Germany $16.905B 12.39
Shionogi (SGIOY) Japan $14.275B 14.30
United Therapeutics (UTHR) United States $13.422B 11.87
Neurocrine Biosciences (NBIX) United States $13.280B 45.49
Orion OYJ (ORINY) Finland $11.409B 27.50
IPSEN (IPSEY) France $10.846B 0.00
Stevanato Group S.p.A (STVN) Italy $7.653B 46.80
Corcept Therapeutics (CORT) United States $7.232B 58.79
Grifols, S.A (GRFS) Spain $7.219B 0.00
Ionis Pharmaceuticals (IONS) United States $6.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.537B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.232B 0.00
Hypermarcas (HYPMY) Brazil $2.971B 19.54
Crinetics Pharmaceuticals (CRNX) United States $2.741B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.563B 8.98
NewAmsterdam Pharma (NAMS) Netherlands $2.558B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.536B 13.71
Centessa Pharmaceuticals (CNTA) United Kingdom $2.032B 0.00
Ocular Therapeutix (OCUL) United States $1.872B 0.00
Endo (NDOI) United States $1.813B 0.00
ARS Pharmaceuticals (SPRY) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.693B 0.00
Evotec AG (EVO) Germany $1.506B 0.00
Dyne Therapeutics (DYN) United States $1.309B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Harrow (HROW) United States $1.267B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.209B 24.18
Avadel Pharmaceuticals (AVDL) Ireland $1.028B 0.00
Ardelyx (ARDX) United States $1.010B 0.00
Collegium Pharmaceutical (COLL) United States $1.003B 5.41
Enliven Therapeutics (ELVN) United States $0.985B 0.00
Akebia Therapeutics (AKBA) United States $0.922B 0.00
ProKidney (PROK) United States $0.811B 0.00
Xeris Biopharma Holdings (XERS) United States $0.782B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.687B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.621B 0.00
Organogenesis (ORGO) United States $0.605B 0.00
Zevra Therapeutics (ZVRA) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.585B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.564B 11.33
Theravance Biopharma (TBPH) United States $0.552B 0.00
Bioventus (BVS) United States $0.537B 13.62
Oruka Therapeutics (ORKA) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.501B 10.46
Savara (SVRA) United States $0.453B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.356B 9.61
AleAnna (ANNA) United States $0.354B 0.00
Nanobiotix S.A (NBTX) France $0.327B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.311B 0.00
Aldeyra Therapeutics (ALDX) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.291B 0.00
Nektar Therapeutics (NKTR) United States $0.284B 0.00
Heron Therapeutics (HRTX) United States $0.282B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
OmniAb (OABI) United States $0.239B 0.00
Larimar Therapeutics (LRMR) United States $0.226B 0.00
MediWound (MDWD) Israel $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.191B 0.00
China SXT Pharmaceuticals (SXTC) China $0.179B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Liminatus Pharma (LIMN) United States $0.174B 0.00
Aclaris Therapeutics (ACRS) United States $0.168B 0.00
Profound Medical (PROF) Canada $0.164B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.144B 0.00
Korro Bio (KRRO) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
Achieve Life Sciences (ACHV) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.088B 20.06
Metagenomi (MGX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Surrozen (SRZN) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Avalo Therapeutics (AVTX) United States $0.071B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Rafael Holdings (RFL) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Wellgistics Health (WGRX) United States $0.067B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
DURECT (DRRX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.78
ElectroCore (ECOR) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.38
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Lyra Therapeutics (LYRA) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.10
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00